Constellium SE
NYSE:CSTMAluminum
+$0.32 today
- Market cap
- $2.88B
- Beta
- 1.54
- P/E (TTM)
- 10.7
- EPS (TTM)
- $3.17
Volume 1.46M
Average 2.27M
CSTM Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Constellium SENYSE: CSTM
Financing Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Financing cash flow grows 231.0% year over year
Q3 FY2026 financing cash flow of $133M (cash outflow) rose 231.0% year over year. Sequentially, it rose 87.3% from the prior quarter. Over 3 fiscal years it compounded at +7.3% a year.
Context
- Financing cash flow amounted to 2.5% of revenue in FY2025, up 1.7 pp from a year earlier.
- Financing cash flow grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
Mixed currencies · from the cash flow
- Latest · FY2025
- (207.94M) USD
- Year-over-year change
- —
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (207.94M) | — |
| FY2024 | 2024-12-31 | (54.08M) | +68.9% |
| FY2023 | 2023-12-31 | (174M) | -3.5% |
| FY2022 | 2022-12-31 | (168.16M) | +61.3% |
| FY2021 | 2021-12-31 | (435M) | — |
Financing Cash Flow vs competitors
How CSTM compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Financing cash flow amounts to 3.0% of revenue for CSTM, versus a peer median of 3.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$815.45M BRL | -48.7% | — | 1.8% | |
| FY2026 | ZAR 771.92M ZAR | +74.2% | +13.2% | 7.2% | |
| LTM Sep 2026 | $298.06M USD | — | +7.3% | 3.0% | |
| LTM Sep 2026 | $227.5M USD | +17.6% | +10.9% | 3.5% | |
| LTM Jun 2026 | $178.31M USD | +389.3% | — | 15.1% | |
| LTM Jun 2026 | $128M USD | -61.2% | -41.5% | 6.9% | |
| LTM Sep 2026 | $122.9M USD | -196.9% | -41.2% | 4.1% | |
| LTM Jun 2026 | $120.2M USD | -7.8% | -53.7% | 1.8% | |
| LTM Jun 2026 | $107.8M USD | +362.7% | -7.7% | 2.6% | |
| LTM Jun 2026 | $99.73M USD | -371.7% | — | 9.5% | |
| LTM Jul 2026 | $5.56M USD | -93.4% | -34.9% | 0.3% | |
| Peer median (excluding CSTM) | — | -28.2% | -34.9% | 3.8% | |
Competitors are the stored peer set for CSTM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 · EUR | FY2022 Dec 2022 · EUR | FY2023 Dec 2023 · EUR | FY2024 Dec 2024 · EUR | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Net Income | 296.64M | 316.34M | 152M | 54.08M | 272.92M |
| Depreciation & Amortization | 302.3M | 287M | 275.07M | 293.57M | 330M |
| Deferred Income Tax | 55M | (133.47M) | 75M | 72.43M | 0 |
| Stock-Based Compensation | 15M | 0 | 0 | 0 | 0 |
| Change in Working Capital | (261M) | (90.38M) | (119M) | (181.55M) | (222.93M) |
| Accounts Receivables | (227M) | 162.9M | (37M) | (48.29M) | (202.94M) |
| Inventory | (435M) | (253.28M) | 202M | (23.18M) | (148.95M) |
| Accounts Payables | 396M | 43.09M | (206M) | (38.63M) | 167.95M |
| Other Working Capital | 5M | (43.09M) | (78M) | (71.46M) | (38.99M) |
| Other Non-Cash Items | (50.94M) | 93.45M | 48.93M | 52.15M | 108.87M |
| Operating Cash Flow | 357M | 472.94M | 432M | 290.68M | 488.85M |
| Capital Expenditures | (232M) | (286.92M) | (366M) | (398.83M) | (329.9M) |
| Acquisitions (Net) | 9.36M | 2.1M | 49M | 9.66M | 11M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 1.64M | (1.05M) | 98M | 82.08M | 3M |
| Investing Cash Flow | (221M) | (285.87M) | (219M) | (307.09M) | (315.9M) |
| Debt Repayment | (377M) | (126.12M) | (166M) | 13.52M | (60.98M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (76.29M) | (114.96M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (58M) | (42.04M) | (8M) | 8.69M | (31.99M) |
| Financing Cash Flow | (435M) | (168.16M) | (174M) | (54.08M) | (207.94M) |
| Effect of Forex Changes | 7M | (8.92M) | 6.84M | (8.69M) | 14M |
| Net Change in Cash | (292M) | 10M | 45.84M | (79.19M) | (20.99M) |
| Free Cash Flow | 125M | 186.02M | 66M | (108.16M) | 158.95M |
Constellium SE
NYSE:CSTM
Intrinsic Alpha fair value
Locked
Current Price
$21.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.